TransMedics Group (TMDX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Voting matters and shareholder proposals
Election of eight directors, with nominees listed for shareholder approval.
Advisory vote on executive compensation for named executive officers.
Proposal to amend the 2019 Stock Incentive Plan, increasing shares available by 2,750,000 and making additional changes.
Ratification of PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Annual meeting to be held virtually on May 20, 2026, allowing shareholder participation online.
Executive compensation and say-on-pay
Advisory vote scheduled on compensation paid to named executive officers.
Proposed amendment to the stock incentive plan includes increasing the share pool and other plan changes.
Latest events from TransMedics Group
- 2025 revenue up 37% with strong margins; 2026 outlook targets 20–25% growth.TMDX
Q4 202513 Apr 2026 - Gen-3 organ preservation and NOP logistics drive growth and global expansion in transplantation.TMDX
44th Annual J.P. Morgan Healthcare Conference12 Apr 2026 - Record revenue growth, expanded equity plan, and robust governance highlight this year's proxy.TMDX
Proxy filing10 Apr 2026 - Pursuing deeper U.S. integration, expanding in Europe, and advancing major clinical trials.TMDX
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - OCS Kidney and next-gen systems target clinical and margin gains, with global expansion ahead.TMDX
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Q2 revenue up 118% to $114.3M, net income $12.2M, and guidance raised on strong growth.TMDX
Q2 20242 Feb 2026 - Integrated clinical and aviation model accelerates transplant growth and operational leverage.TMDX
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Integrated logistics and digital innovation are fueling rapid growth and market expansion.TMDX
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 revenue surged 64% to $108.8M, with net income of $4.2M and strong growth outlook.TMDX
Q3 202418 Jan 2026